Shop ATS / CDC / IDSA Drug-Susceptible Tuberculosis

Drug-Susceptible Tuberculosis

American Thoracic SocietyCenters for Disease Control and PreventionInfectious Diseases Society of America
Published: August 2016
Print Copy Information:
  • 24 pages
  • Spiral Bound
  • 80# Aqueous Coating
  • 4.25" x 7.25"
  • Ships in 5 – 10 business days
What's Inside
Bulk and Institutional Ordering
About the Authors
Additional Information
  • Key Points 
  • Recommended Treatment Regimens
  • Treatment in Special Situations 
  • Figures 
    • Factors to be considered in deciding to initiate treatment empirically for active tuberculosis
    • Baseline And Follow-Up Evaluations For Patients Treated With First-Line Tuberculosis Medications 
  • Tables 
    • Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis Caused by Drug-Susceptible Organisms
    • Doses of Antituberculosis Drugs for Adults and Children 
    • Possible Components of a Multifaceted, Patient-Centered Treatment Strategy
    • Examples of Priority Situations for the Use of Directly Observed Therapy
    • Management of Treatment Interruptions
    • Other Causes of Abnormal Liver Function Tests That Should Be Excluded
    • Conditions or Situations in Which Therapeutic Drug Monitoring May Be Helpful
    • Clinically Significant Drug–Drug Interactions Involving the Rifamycins
    • Suggested Pyrazinamide Doses, Using Whole Tablets, for Adults Weighing 40–90 kg
    • Suggested Ethambutol Dosages, Using Whole Tablets, for Adults Weighing 40–90 kg
    • Dosing Recommendations for Adult Patients With Reduced Renal Function
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

The roots of the American Thoracic Society reach back to 1905, when a small group of physicians decided that the best way to improve care for tuberculosis patients was to share their experiences and discoveries. Today, the ATS has grown into an international society with more than 15,000 members. In this introductory section, you will find information about the people and programs that make the ATS the world's leading medical association dedicated to advancing our clinical and scientific understanding of pulmonary diseases, critical illnesses and sleep-related breathing disorders.

The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA's purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.


This resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers after consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary.

You can also find this product included in these bundles!

Need help?